https://www.biohealthcapital.com Advancing Science. Accelerating Innovation. Fri, 13 Sep 2024 18:14:06 +0000 en-US hourly 1 https://wordpress.org/?v=5.7.15 https://www.biohealthcapital.com/speaker/dendy-young/ http://bhcrforum.dmvg.us/?post_type=speaker&p=764 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sat, 14 Jan 2017 13:42:38 +0000 Dendy Young is the Managing Partner of McLean Capital, LLC, a private equity firm, based in McLean, VA, which focuses on investments in early-stage companies. He is also a member...]]> https://www.biohealthcapital.com/speaker/bing-yao/ http://www.bhcrforum.com/?post_type=speaker&p=1011 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sat, 14 Jan 2017 09:00:29 +0000 Dr. Bing Yao is the CEO of Viela Bio, a spinoff from MedImmune. He has 20 years’ experience in the biopharmaceutical industry, with a track record of leading successful discovery...]]> https://www.biohealthcapital.com/speaker/christy-wyskiel/ http://bhcrforum.dmvg.us/?post_type=speaker&p=260 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Thu, 12 Jan 2017 21:00:37 +0000 Christy Wyskiel is Senior Advisor to the President of Johns Hopkins University on matters of innovation, commercialization, and entrepreneurship. In her role, she heads up Johns Hopkins Technology Ventures, which...]]> https://www.biohealthcapital.com/speaker/r-jacob-vogelstein/ http://bhcrforum.dmvg.us/?post_type=speaker&p=808 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Wed, 11 Jan 2017 12:00:29 +0000 Jacob Vogelstein is a Partner and Portfolio Manager at Camden Partners Holdings, LLC, where he focuses on Camden’s seed strategy. He currently serves on the board of Cage Pharmaceuticals, eNeura,...]]> https://www.biohealthcapital.com/speaker/amitabh-varshney/ http://bhcrforum.dmvg.us/?post_type=speaker&p=821 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Wed, 11 Jan 2017 09:00:37 +0000 Amitabh Varshney is a Professor of Computer Science and Dean of the College of Computer, Mathematical, and Natural Sciences at the University of Maryland, College Park. In his research, Varshney...]]> https://www.biohealthcapital.com/speaker/jeffrey-ulmer/ http://bhcrforum.dmvg.us/?post_type=speaker&p=879 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Tue, 10 Jan 2017 13:00:07 +0000 Dr. Jeffrey Ulmer received his B.Sc. with honors from the Department of Chemistry at the University of Regina and was the recipient of the Merit Award of the Society of...]]> https://www.biohealthcapital.com/speaker/john-trainer/ http://bhcrforum.dmvg.us/?post_type=speaker&p=319 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Mon, 09 Jan 2017 15:00:06 +0000  John Trainer is the leader of AstraZeneca’s Partnering and Strategy group, which focuses on business deals ranging from acquisitions and clinical collaborations to licensing agreements and new industry partnerships.  John...]]> https://www.biohealthcapital.com/speaker/mike-thomas/ http://www.bhcrforum.com/?post_type=speaker&p=978 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Mon, 09 Jan 2017 10:00:06 +0000 Mike is a Director of Inova Personalized Health Accelerator. He is responsible for identifying and investing in all IPHA companies and expediting their achievement of value creating milestones. As a...]]> https://www.biohealthcapital.com/speaker/marshall-summar/ http://bhcrforum.dmvg.us/?post_type=speaker&p=840 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sun, 08 Jan 2017 17:00:57 +0000 Dr. Summar is well-known for his pioneering work in caring for children diagnosed with rare diseases. He joined Children’s National in 2010 from Vanderbilt University. At Children’s National he leads...]]> https://www.biohealthcapital.com/speaker/todd-stottlemeyer/ http://www.bhcrforum.com/?post_type=speaker&p=983 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sun, 08 Jan 2017 16:45:10 +0000 Todd Stottlemyer leads the 117-acre Inova Center for Personalized Health campus, which includes the Inova Schar Cancer Institute and the Inova Translational Medicine Institute. Stottlemyer also provides executive leadership for...]]> https://www.biohealthcapital.com/speaker/benjamin-solomon/ http://bhcrforum.dmvg.us/?post_type=speaker&p=902 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sun, 08 Jan 2017 16:00:28 +0000 Ben Solomon is a board-certified pediatric geneticist who focuses on the use of genetics and genomics to identify, understand and care for patients with both rare and common genetic conditions...]]> https://www.biohealthcapital.com/speaker/robert-silverman/ http://bhcrforum.dmvg.us/?post_type=speaker&p=395 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sun, 08 Jan 2017 15:00:09 +0000 Bob Silverman leads the “External Drug Discovery Partnering” team of Roche Partnering. Among other matters, Bob is responsible for delivering a structured and systematic approach to venture capital that translates...]]> https://www.biohealthcapital.com/speaker/paul-silber-phd/ http://bhcrforum.dmvg.us/?post_type=speaker&p=400 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sun, 08 Jan 2017 14:45:04 +0000 For the past 12 years Dr. Silber has been an active angel investor and strategic advisor in the mid-Atlantic region. He is a Founding Principal of Blu Venture Investors and...]]> https://www.biohealthcapital.com/speaker/bret-schreiber/ http://bhcrforum.dmvg.us/?post_type=speaker&p=748 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sun, 08 Jan 2017 05:00:36 +0000 Prior to the Department of Commerce, Bret Schreiber has worked for over 20 years in the field of government and community relations, driving policy and economic development initiatives and developing...]]> https://www.biohealthcapital.com/speaker/michael-l-salgaller/ http://www.bhcrforum.com/?post_type=speaker&p=1008 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sun, 08 Jan 2017 04:00:28 +0000 Dr. Michael Salgaller leads the Invention Development and Marketing Unit within the National Cancer Institute’s Technology Transfer Center, where he leverages over 20 years of business, scientific, and investment experience...]]> https://www.biohealthcapital.com/speaker/tina-reed/ http://www.bhcrforum.com/?post_type=speaker&p=992 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Sat, 07 Jan 2017 09:00:54 +0000 Tina Reed is the Executive Healthcare & Hospitals Editor who oversees FierceHealthcare, FierceHospitals and FiercePracticeManagement. She has been reporting on health for about a decade, previously writing on the business of healthcare,...]]> https://www.biohealthcapital.com/speaker/steve-projan/ http://bhcrforum.dmvg.us/?post_type=speaker&p=757 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Thu, 05 Jan 2017 13:30:26 +0000 Dr. Steve Projan is the Head of Infectious Diseases & Vaccines Innovative Medicines unit (iMED) at MedImmune, leading a cross-functional team dedicated to the therapeutic area strategy, prioritization and advancement...]]> https://www.biohealthcapital.com/speaker/david-a-present/ http://bhcrforum.dmvg.us/?post_type=speaker&p=771 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Thu, 05 Jan 2017 13:00:18 +0000 Dr. Present began his career over 35 years ago as a university-based orthopedic oncological surgeon, later becoming Chief of Orthopedic Surgical Oncology and Assistant Professor of Orthopedic Surgery at NYU...]]> https://www.biohealthcapital.com/speaker/cherine-eldumiati-plumaker/ http://bhcrforum.dmvg.us/?post_type=speaker&p=774 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Thu, 05 Jan 2017 12:00:17 +0000 Cherine E. Plumaker began her career at Weiss Peck & Greer-Farber Present Fund as an equity analyst focusing on the healthcare and consumer industries. In rapid succession, she became portfolio...]]> https://www.biohealthcapital.com/speaker/james-powers/ http://bhcrforum.dmvg.us/?post_type=speaker&p=834 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Thu, 05 Jan 2017 11:00:23 +0000 Jim serves as chairman and CEO of HemoShear Therapeutics. Prior to joining HemoShear in 2009, he spent 18 years with PRA Health Sciences where he was a member of the...]]> https://www.biohealthcapital.com/speaker/emanuel-petricoin/ http://bhcrforum.dmvg.us/?post_type=speaker&p=844 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Thu, 05 Jan 2017 10:15:23 +0000 Dr. Emanuel F Petricoin is the Chief Science Officer and Co-Founder of Perthera, Inc., Perthera is a leading precision medicine company that empowers all cancer patients and oncologists globally with...]]> https://www.biohealthcapital.com/speaker/jay-a-perman-md/ http://bhcrforum.dmvg.us/?post_type=speaker&p=752 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Thu, 05 Jan 2017 10:00:47 +0000 Jay A. Perman, MD, is president of the University of Maryland, Baltimore (UMB)—Maryland’s only public health, law, and human services university. A pediatric gastroenterologist, Dr. Perman continues to practice medicine...]]> https://www.biohealthcapital.com/speaker/vasum-peiris/ http://bhcrforum.dmvg.us/?post_type=speaker&p=930 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Thu, 05 Jan 2017 09:30:40 +0000 As Chief Medical Officer for Pediatrics and Special Populations at the U.S. FDA CDRH, Vasum provides executive and clinical leadership on Center policies and initiatives associated with medical devices intended...]]> https://www.biohealthcapital.com/speaker/kurt-newman/ http://bhcrforum.dmvg.us/?post_type=speaker&p=905 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Tue, 03 Jan 2017 10:00:52 +0000 Kurt Newman, MD, is President and CEO of Children’s National Health System. Located in Washington, D.C., Children’s National is ranked one of the nation’s best pediatric hospitals by U.S. News...]]> https://www.biohealthcapital.com/speaker/sara-nayeem-md/ http://bhcrforum.dmvg.us/?post_type=speaker&p=148 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Tue, 03 Jan 2017 09:00:30 +0000 Sara joined NEA’s healthcare team in 2009 and focuses on investments in biopharmaceutical companies. She serves on the boards of Mersana, Cydan, Vtesse and Therachon, and Imara, as a board...]]> https://www.biohealthcapital.com/speaker/john-mumm/ http://bhcrforum.dmvg.us/?post_type=speaker&p=760 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Mon, 02 Jan 2017 12:30:39 +0000 John received an MS from Stanford University and both an MS and PhD from MD Anderson Cancer Center where he discovered that IL-10 directly activates anti-tumor CD8+ T cells. John...]]> https://www.biohealthcapital.com/speaker/jason-miller/ http://www.bhcrforum.com/?post_type=speaker&p=1005 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Mon, 02 Jan 2017 12:00:59 +0000 Jason Miller is the Chief Executive Officer of the Greater Washington Partnership. The Partnership is a civic alliance of the region’s leading employers and entrepreneurs committed to making the Capital Region of...]]> https://www.biohealthcapital.com/speaker/matthew-mulvey/ http://bhcrforum.dmvg.us/?post_type=speaker&p=146 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Mon, 02 Jan 2017 12:00:25 +0000 Mulvey holds a PhD in Virology from Ian Mohr’s lab at NYU Langone Medical Center. Mohr and Mulvey discovered, patented, and characterized the first oncolytic virus capable of resisting the...]]> https://www.biohealthcapital.com/speaker/beth-meagher/ http://bhcrforum.dmvg.us/?post_type=speaker&p=244 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Mon, 02 Jan 2017 11:00:46 +0000 Ms. Meagher has more than 19 years of experience leading strategic initiatives for clients in the commercial, government, and non-profit sectors. She leads Deloitte’s Federal Strategy practice, which has grown...]]> https://www.biohealthcapital.com/speaker/joel-marcus/ http://bhcrforum.dmvg.us/?post_type=speaker&p=490 scott@delmarvagroup.com (admin) https://www.biohealthcapital.com/wp-content/uploads/2017/01/Dendy_small.png"/> Mon, 02 Jan 2017 09:00:39 +0000 Joel S. Marcus is the Chairman, Chief Executive Officer, and Founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments (NYSE:ARE), an urban office REIT uniquely focused on collaborative...]]>